The relevant information included in this section is exactly as published on the website of the National Securities Market Commission (CNMV)
Filter results
| Date | Title | |
|---|---|---|
| 28/07/2021 | First half 2021 results press release | |
| 13/05/2021 | First quarter 2021 results press release | |
| 29/04/2021 | ROVI increases its fill-finish capacity for the COVID-19 Vaccine Moderna | |
| 12/04/2021 | ROVI participates in the manufacture of the active substance of Moderna’s COVID-19 vaccine | |
| 2/03/2021 | Update on Doria® regulatory processes | |
| 24/02/2021 | Full year 2020 results press release |